+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Galactosemia Market by Type, Diagnosis Methods, Treatment Approaches, Age Group, End Users, Products, Tests And Assays - Global Forecast 2025-2030- Product Image
Galactosemia Market by Type, Diagnosis Methods, Treatment Approaches, Age Group, End Users, Products, Tests And Assays - Global Forecast 2025-2030- Product Image
Sale

Galactosemia Market by Type, Diagnosis Methods, Treatment Approaches, Age Group, End Users, Products, Tests And Assays - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 194 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 6016541
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Galactosemia Market grew from USD 504.25 million in 2023 to USD 531.54 million in 2024. It is expected to continue growing at a CAGR of 6.86%, reaching USD 802.53 million by 2030.

Galactosemia is a rare inherited metabolic disorder characterized by an inability to properly metabolize galactose, a sugar found in milk and dairy products. The scope of research and application of galactosemia extends to its early detection, management, and treatment, given the disease's potentially severe impact on health if untreated. This disorder necessitates accurate newborn screening protocols, dietary management strategies, and advancements in enzyme replacement therapies. The market for galactosemia is driven by the rising demand for rapid and precise diagnostic technologies, increasing awareness of rare metabolic disorders, and ongoing research into novel therapeutic interventions. Key factors influencing market growth include advancements in genetic research, which have improved diagnostic capabilities, and the development of new treatments aiming to reduce disease burden and improve patient quality of life. However, challenges such as limited patient populations, high costs of R&D, and complex regulatory pathways hinder market advancement. Additionally, the lack of awareness and limited accessibility to advanced treatments in emerging economies remain significant barriers. Potential opportunities lie in the expansion of newborn screening programs, increased funding for rare disease research, and the development of gene therapies and metabolic treatment options. Businesses can capitalize on these opportunities by investing in collaborations with research institutions, and focusing on personalized medicine approaches. Innovation areas include the development of more effective enzyme replacement therapies, oral medications for improved adherence, and enhancements in genetic screening methods. The nature of the market is niche and highly specialized, requiring companies to focus on quality, efficacy, and strategic collaborations to achieve growth. To effectively navigate this market, businesses should prioritize establishing strong ties with healthcare providers, patient advocacy groups, and leveraging digital technologies for improved patient outcomes and education.

Understanding Market Dynamics in the Galactosemia Market

The Galactosemia Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Growing collaborations between academic institutions and biotech firms for research and drug development
    • Development and commercialization of enzyme replacement therapies to address metabolic disorders
    • Increasing patient advocacy and support groups driving research and policy changes
    • Advancements in personalized medicine and targeted treatment approaches, offering clinical benefits
  • Market Restraints
    • Low prevalence of galactosemia limiting the potential for treatments and therapies
  • Market Opportunities
    • Expanding treatment options and improving early detection methods for galactosemia in neonates
    • Developing advanced diagnostic tools and targeted therapies to address specific enzyme deficiencies in adult patients with galactosemia
    • Innovative approaches to genetic counseling and family support services for those impacted by galactosemia
  • Market Challenges
    • Lack of awareness and timely diagnosis of galactosemia leading to delayed treatment

Exploring Porter’s Five Forces for the Galactosemia Market

Porter’s Five Forces framework further strengthens the insights of the Galactosemia Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Galactosemia Market

External macro-environmental factors deeply influence the performance of the Galactosemia Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Galactosemia Market

The Galactosemia Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Galactosemia Market

The Galactosemia Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Galactosemia Market

The Galactosemia Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Galactosemia Market, highlighting leading vendors and their innovative profiles. These include AbbVie, Amgen, Audentes Therapeutics, BioMarin Pharmaceutical Inc., BridgeBio Pharma, Erytech Pharma, GlaxoSmithKline, Hospira, Johnson & Johnson, LogicBio Therapeutics, Moderna, Novartis, Orphalan, Pfizer, Roche, Sanofi, Sarepta Therapeutics, Ultragenyx Pharmaceutical Inc., uniQure, and Vertex Pharmaceuticals.

Market Segmentation & Coverage

This research report categorizes the Galactosemia Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Type
    • Classic Galactosemia
      • GALE Deficiency
      • GALK Deficiency
      • GALT Deficiency
    • Clinical Variant
    • Duarte Variant
  • Diagnosis Methods
    • Enzyme Assay
    • Genetic Testing
    • Newborn Screening Tests
      • Heel Prick Test
      • Mass Spectrometry
  • Treatment Approaches
    • Dietary Management
      • Calcium Supplements
      • Galactose-Restricted Diet
      • Soy-Based Formula
    • Enzyme Replacement Therapy
    • Gene Therapy
  • Age Group
    • Adults
    • Children
    • Infants
    • Newborns
  • End Users
    • Academic Institutions
    • Diagnostic Laboratories
      • Clinical Laboratories
      • Research Laboratories
    • Hospitals
      • Private Hospitals
      • Public Hospitals
  • Products
    • Formulas
      • Lactose-Free Formula
      • Soy-Based Formula
    • Pharmaceuticals
    • Supplements
      • Calcium Supplements
      • Vitamin Supplements
  • Tests And Assays
    • Confirmatory Tests
      • DNA Testing
      • Enzyme Assays
    • Follow-Up Tests
    • Screening Tests
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing collaborations between academic institutions and biotech firms for research and drug development
5.1.1.2. Development and commercialization of enzyme replacement therapies to address metabolic disorders
5.1.1.3. Increasing patient advocacy and support groups driving research and policy changes
5.1.1.4. Advancements in personalized medicine and targeted treatment approaches, offering clinical benefits
5.1.2. Restraints
5.1.2.1. Low prevalence of galactosemia limiting the potential for treatments and therapies
5.1.3. Opportunities
5.1.3.1. Expanding treatment options and improving early detection methods for galactosemia in neonates
5.1.3.2. Developing advanced diagnostic tools and targeted therapies to address specific enzyme deficiencies in adult patients with galactosemia
5.1.3.3. Innovative approaches to genetic counseling and family support services for those impacted by galactosemia
5.1.4. Challenges
5.1.4.1. Lack of awareness and timely diagnosis of galactosemia leading to delayed treatment
5.2. Market Segmentation Analysis
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental

6. Galactosemia Market, by Type
6.1. Introduction
6.2. Classic Galactosemia
6.2.1. GALE Deficiency
6.2.2. GALK Deficiency
6.2.3. GALT Deficiency
6.3. Clinical Variant
6.4. Duarte Variant

7. Galactosemia Market, by Diagnosis Methods
7.1. Introduction
7.2. Enzyme Assay
7.3. Genetic Testing
7.4. Newborn Screening Tests
7.4.1. Heel Prick Test
7.4.2. Mass Spectrometry

8. Galactosemia Market, by Treatment Approaches
8.1. Introduction
8.2. Dietary Management
8.2.1. Calcium Supplements
8.2.2. Galactose-Restricted Diet
8.2.3. Soy-Based Formula
8.3. Enzyme Replacement Therapy
8.4. Gene Therapy

9. Galactosemia Market, by Age Group
9.1. Introduction
9.2. Adults
9.3. Children
9.4. Infants
9.5. Newborns

10. Galactosemia Market, by End Users
10.1. Introduction
10.2. Academic Institutions
10.3. Diagnostic Laboratories
10.3.1. Clinical Laboratories
10.3.2. Research Laboratories
10.4. Hospitals
10.4.1. Private Hospitals
10.4.2. Public Hospitals

11. Galactosemia Market, by Products
11.1. Introduction
11.2. Formulas
11.2.1. Lactose-Free Formula
11.2.2. Soy-Based Formula
11.3. Pharmaceuticals
11.4. Supplements
11.4.1. Calcium Supplements
11.4.2. Vitamin Supplements

12. Galactosemia Market, by Tests And Assays
12.1. Introduction
12.2. Confirmatory Tests
12.2.1. DNA Testing
12.2.2. Enzyme Assays
12.3. Follow-Up Tests
12.4. Screening Tests

13. Americas Galactosemia Market
13.1. Introduction
13.2. Argentina
13.3. Brazil
13.4. Canada
13.5. Mexico
13.6. United States

14. Asia-Pacific Galactosemia Market
14.1. Introduction
14.2. Australia
14.3. China
14.4. India
14.5. Indonesia
14.6. Japan
14.7. Malaysia
14.8. Philippines
14.9. Singapore
14.10. South Korea
14.11. Taiwan
14.12. Thailand
14.13. Vietnam

15. Europe, Middle East & Africa Galactosemia Market
15.1. Introduction
15.2. Denmark
15.3. Egypt
15.4. Finland
15.5. France
15.6. Germany
15.7. Israel
15.8. Italy
15.9. Netherlands
15.10. Nigeria
15.11. Norway
15.12. Poland
15.13. Qatar
15.14. Russia
15.15. Saudi Arabia
15.16. South Africa
15.17. Spain
15.18. Sweden
15.19. Switzerland
15.20. Turkey
15.21. United Arab Emirates
15.22. United Kingdom

16. Competitive Landscape
16.1. Market Share Analysis, 2023
16.2. FPNV Positioning Matrix, 2023
16.3. Competitive Scenario Analysis
16.4. Strategy Analysis & Recommendation


List of Figures
FIGURE 1. GALACTOSEMIA MARKET RESEARCH PROCESS
FIGURE 2. GALACTOSEMIA MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL GALACTOSEMIA MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL GALACTOSEMIA MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL GALACTOSEMIA MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL GALACTOSEMIA MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 7. GLOBAL GALACTOSEMIA MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL GALACTOSEMIA MARKET SIZE, BY DIAGNOSIS METHODS, 2023 VS 2030 (%)
FIGURE 9. GLOBAL GALACTOSEMIA MARKET SIZE, BY DIAGNOSIS METHODS, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL GALACTOSEMIA MARKET SIZE, BY TREATMENT APPROACHES, 2023 VS 2030 (%)
FIGURE 11. GLOBAL GALACTOSEMIA MARKET SIZE, BY TREATMENT APPROACHES, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. GLOBAL GALACTOSEMIA MARKET SIZE, BY AGE GROUP, 2023 VS 2030 (%)
FIGURE 13. GLOBAL GALACTOSEMIA MARKET SIZE, BY AGE GROUP, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. GLOBAL GALACTOSEMIA MARKET SIZE, BY END USERS, 2023 VS 2030 (%)
FIGURE 15. GLOBAL GALACTOSEMIA MARKET SIZE, BY END USERS, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. GLOBAL GALACTOSEMIA MARKET SIZE, BY PRODUCTS, 2023 VS 2030 (%)
FIGURE 17. GLOBAL GALACTOSEMIA MARKET SIZE, BY PRODUCTS, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. GLOBAL GALACTOSEMIA MARKET SIZE, BY TESTS AND ASSAYS, 2023 VS 2030 (%)
FIGURE 19. GLOBAL GALACTOSEMIA MARKET SIZE, BY TESTS AND ASSAYS, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. AMERICAS GALACTOSEMIA MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 21. AMERICAS GALACTOSEMIA MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 22. UNITED STATES GALACTOSEMIA MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 23. UNITED STATES GALACTOSEMIA MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 24. ASIA-PACIFIC GALACTOSEMIA MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 25. ASIA-PACIFIC GALACTOSEMIA MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 26. EUROPE, MIDDLE EAST & AFRICA GALACTOSEMIA MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 27. EUROPE, MIDDLE EAST & AFRICA GALACTOSEMIA MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 28. GALACTOSEMIA MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 29. GALACTOSEMIA MARKET, FPNV POSITIONING MATRIX, 2023


List of Tables
TABLE 1. GALACTOSEMIA MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL GALACTOSEMIA MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL GALACTOSEMIA MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL GALACTOSEMIA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GALACTOSEMIA MARKET DYNAMICS
TABLE 7. GLOBAL GALACTOSEMIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL GALACTOSEMIA MARKET SIZE, BY CLASSIC GALACTOSEMIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL GALACTOSEMIA MARKET SIZE, BY GALE DEFICIENCY, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL GALACTOSEMIA MARKET SIZE, BY GALK DEFICIENCY, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL GALACTOSEMIA MARKET SIZE, BY GALT DEFICIENCY, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL GALACTOSEMIA MARKET SIZE, BY CLASSIC GALACTOSEMIA, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL GALACTOSEMIA MARKET SIZE, BY CLINICAL VARIANT, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL GALACTOSEMIA MARKET SIZE, BY DUARTE VARIANT, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL GALACTOSEMIA MARKET SIZE, BY DIAGNOSIS METHODS, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL GALACTOSEMIA MARKET SIZE, BY ENZYME ASSAY, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL GALACTOSEMIA MARKET SIZE, BY GENETIC TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL GALACTOSEMIA MARKET SIZE, BY NEWBORN SCREENING TESTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL GALACTOSEMIA MARKET SIZE, BY HEEL PRICK TEST, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL GALACTOSEMIA MARKET SIZE, BY MASS SPECTROMETRY, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL GALACTOSEMIA MARKET SIZE, BY NEWBORN SCREENING TESTS, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL GALACTOSEMIA MARKET SIZE, BY TREATMENT APPROACHES, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL GALACTOSEMIA MARKET SIZE, BY DIETARY MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL GALACTOSEMIA MARKET SIZE, BY CALCIUM SUPPLEMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL GALACTOSEMIA MARKET SIZE, BY GALACTOSE-RESTRICTED DIET, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL GALACTOSEMIA MARKET SIZE, BY SOY-BASED FORMULA, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL GALACTOSEMIA MARKET SIZE, BY DIETARY MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL GALACTOSEMIA MARKET SIZE, BY ENZYME REPLACEMENT THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL GALACTOSEMIA MARKET SIZE, BY GENE THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL GALACTOSEMIA MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL GALACTOSEMIA MARKET SIZE, BY ADULTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL GALACTOSEMIA MARKET SIZE, BY CHILDREN, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL GALACTOSEMIA MARKET SIZE, BY INFANTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL GALACTOSEMIA MARKET SIZE, BY NEWBORNS, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL GALACTOSEMIA MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL GALACTOSEMIA MARKET SIZE, BY ACADEMIC INSTITUTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL GALACTOSEMIA MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL GALACTOSEMIA MARKET SIZE, BY CLINICAL LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL GALACTOSEMIA MARKET SIZE, BY RESEARCH LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL GALACTOSEMIA MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL GALACTOSEMIA MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL GALACTOSEMIA MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL GALACTOSEMIA MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL GALACTOSEMIA MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL GALACTOSEMIA MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL GALACTOSEMIA MARKET SIZE, BY FORMULAS, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL GALACTOSEMIA MARKET SIZE, BY LACTOSE-FREE FORMULA, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL GALACTOSEMIA MARKET SIZE, BY SOY-BASED FORMULA, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL GALACTOSEMIA MARKET SIZE, BY FORMULAS, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL GALACTOSEMIA MARKET SIZE, BY PHARMACEUTICALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL GALACTOSEMIA MARKET SIZE, BY SUPPLEMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL GALACTOSEMIA MARKET SIZE, BY CALCIUM SUPPLEMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL GALACTOSEMIA MARKET SIZE, BY VITAMIN SUPPLEMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL GALACTOSEMIA MARKET SIZE, BY SUPPLEMENTS, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL GALACTOSEMIA MARKET SIZE, BY TESTS AND ASSAYS, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL GALACTOSEMIA MARKET SIZE, BY CONFIRMATORY TESTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL GALACTOSEMIA MARKET SIZE, BY DNA TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL GALACTOSEMIA MARKET SIZE, BY ENZYME ASSAYS, BY REGION, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL GALACTOSEMIA MARKET SIZE, BY CONFIRMATORY TESTS, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL GALACTOSEMIA MARKET SIZE, BY FOLLOW-UP TESTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL GALACTOSEMIA MARKET SIZE, BY SCREENING TESTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 62. AMERICAS GALACTOSEMIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 63. AMERICAS GALACTOSEMIA MARKET SIZE, BY CLASSIC GALACTOSEMIA, 2018-2030 (USD MILLION)
TABLE 64. AMERICAS GALACTOSEMIA MARKET SIZE, BY DIAGNOSIS METHODS, 2018-2030 (USD MILLION)
TABLE 65. AMERICAS GALACTOSEMIA MARKET SIZE, BY NEWBORN SCREENING TESTS, 2018-2030 (USD MILLION)
TABLE 66. AMERICAS GALACTOSEMIA MARKET SIZE, BY TREATMENT APPROACHES, 2018-2030 (USD MILLION)
TABLE 67. AMERICAS GALACTOSEMIA MARKET SIZE, BY DIETARY MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 68. AMERICAS GALACTOSEMIA MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 69. AMERICAS GALACTOSEMIA MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 70. AMERICAS GALACTOSEMIA MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 71. AMERICAS GALACTOSEMIA MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 72. AMERICAS GALACTOSEMIA MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 73. AMERICAS GALACTOSEMIA MARKET SIZE, BY FORMULAS, 2018-2030 (USD MILLION)
TABLE 74. AMERICAS GALACTOSEMIA MARKET SIZE, BY SUPPLEMENTS, 2018-2030 (USD MILLION)
TABLE 75. AMERICAS GALACTOSEMIA MARKET SIZE, BY TESTS AND ASSAYS, 2018-2030 (USD MILLION)
TABLE 76. AMERICAS GALACTOSEMIA MARKET SIZE, BY CONFIRMATORY TESTS, 2018-2030 (USD MILLION)
TABLE 77. AMERICAS GALACTOSEMIA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 78. ARGENTINA GALACTOSEMIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 79. ARGENTINA GALACTOSEMIA MARKET SIZE, BY CLASSIC GALACTOSEMIA, 2018-2030 (USD MILLION)
TABLE 80. ARGENTINA GALACTOSEMIA MARKET SIZE, BY DIAGNOSIS METHODS, 2018-2030 (USD MILLION)
TABLE 81. ARGENTINA GALACTOSEMIA MARKET SIZE, BY NEWBORN SCREENING TESTS, 2018-2030 (USD MILLION)
TABLE 82. ARGENTINA GALACTOSEMIA MARKET SIZE, BY TREATMENT APPROACHES, 2018-2030 (USD MILLION)
TABLE 83. ARGENTINA GALACTOSEMIA MARKET SIZE, BY DIETARY MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 84. ARGENTINA GALACTOSEMIA MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 85. ARGENTINA GALACTOSEMIA MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 86. ARGENTINA GALACTOSEMIA MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 87. ARGENTINA GALACTOSEMIA MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 88. ARGENTINA GALACTOSEMIA MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 89. ARGENTINA GALACTOSEMIA MARKET SIZE, BY FORMULAS, 2018-2030 (USD MILLION)
TABLE 90. ARGENTINA GALACTOSEMIA MARKET SIZE, BY SUPPLEMENTS, 2018-2030 (USD MILLION)
TABLE 91. ARGENTINA GALACTOSEMIA MARKET SIZE, BY TESTS AND ASSAYS, 2018-2030 (USD MILLION)
TABLE 92. ARGENTINA GALACTOSEMIA MARKET SIZE, BY CONFIRMATORY TESTS, 2018-2030 (USD MILLION)
TABLE 93. BRAZIL GALACTOSEMIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 94. BRAZIL GALACTOSEMIA MARKET SIZE, BY CLASSIC GALACTOSEMIA, 2018-2030 (USD MILLION)
TABLE 95. BRAZIL GALACTOSEMIA MARKET SIZE, BY DIAGNOSIS METHODS, 2018-2030 (USD MILLION)
TABLE 96. BRAZIL GALACTOSEMIA MARKET SIZE, BY NEWBORN SCREENING TESTS, 2018-2030 (USD MILLION)
TABLE 97. BRAZIL GALACTOSEMIA MARKET SIZE, BY TREATMENT APPROACHES, 2018-2030 (USD MILLION)
TABLE 98. BRAZIL GALACTOSEMIA MARKET SIZE, BY DIETARY MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 99. BRAZIL GALACTOSEMIA MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 100. BRAZIL GALACTOSEMIA MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 101. BRAZIL GALACTOSEMIA MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 102. BRAZIL GALACTOSEMIA MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 103. BRAZIL GALACTOSEMIA MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 104. BRAZIL GALACTOSEMIA MARKET SIZE, BY FORMULAS, 2018-2030 (USD MILLION)
TABLE 105. BRAZIL GALACTOSEMIA MARKET SIZE, BY SUPPLEMENTS, 2018-2030 (USD MILLION)
TABLE 106. BRAZIL GALACTOSEMIA MARKET SIZE, BY TESTS AND ASSAYS, 2018-2030 (USD MILLION)
TABLE 107. BRAZIL GALACTOSEMIA MARKET SIZE, BY CONFIRMATORY TESTS, 2018-2030 (USD MILLION)
TABLE 108. CANADA GALACTOSEMIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 109. CANADA GALACTOSEMIA MARKET SIZE, BY CLASSIC GALACTOSEMIA, 2018-2030 (USD MILLION)
TABLE 110. CANADA GALACTOSEMIA MARKET SIZE, BY DIAGNOSIS METHODS, 2018-2030 (USD MILLION)
TABLE 111. CANADA GALACTOSEMIA MARKET SIZE, BY NEWBORN SCREENING TESTS, 2018-2030 (USD MILLION)
TABLE 112. CANADA GALACTOSEMIA MARKET SIZE, BY TREATMENT APPROACHES, 2018-2030 (USD MILLION)
TABLE 113. CANADA GALACTOSEMIA MARKET SIZE, BY DIETARY MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 114. CANADA GALACTOSEMIA MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 115. CANADA GALACTOSEMIA MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 116. CANADA GALACTOSEMIA MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 117. CANADA GALACTOSEMIA MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 118. CANADA GALACTOSEMIA MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 119. CANADA GALACTOSEMIA MARKET SIZE, BY FORMULAS, 2018-2030 (USD MILLION)
TABLE 120. CANADA GALACTOSEMIA MARKET SIZE, BY SUPPLEMENTS, 2018-2030 (USD MILLION)
TABLE 121. CANADA GALACTOSEMIA MARKET SIZE, BY TESTS AND ASSAYS, 2018-2030 (USD MILLION)
TABLE 122. CANADA GALACTOSEMIA MARKET SIZE, BY CONFIRMATORY TESTS, 2018-2030 (USD MILLION)
TABLE 123. MEXICO GALACTOSEMIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 124. MEXICO GALACTOSEMIA MARKET SIZE, BY CLASSIC GALACTOSEMIA, 2018-2030 (USD MILLION)
TABLE 125. MEXICO GALACTOSEMIA MARKET SIZE, BY DIAGNOSIS METHODS, 2018-2030 (USD MILLION)
TABLE 126. MEXICO GALACTOSEMIA MARKET SIZE, BY NEWBORN SCREENING TESTS, 2018-2030 (USD MILLION)
TABLE 127. MEXICO GALACTOSEMIA MARKET SIZE, BY TREATMENT APPROACHES, 2018-2030 (USD MILLION)
TABLE 128. MEXICO GALACTOSEMIA MARKET SIZE, BY DIETARY MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 129. MEXICO GALACTOSEMIA MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 130. MEXICO GALACTOSEMIA MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 131. MEXICO GALACTOSEMIA MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 132. MEXICO GALACTOSEMIA MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 133. MEXICO GALACTOSEMIA MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 134. MEXICO GALACTOSEMIA MARKET SIZE, BY FORMULAS, 2018-2030 (USD MILLION)
TABLE 135. MEXICO GALACTOSEMIA MARKET SIZE, BY SUPPLEMENTS, 2018-2030 (USD MILLION)
TABLE 136. MEXICO GALACTOSEMIA MARKET SIZE, BY TESTS AND ASSAYS, 2018-2030 (USD MILLION)
TABLE 137. MEXICO GALACTOSEMIA MARKET SIZE, BY CONFIRMATORY TESTS, 2018-2030 (USD MILLION)
TABLE 138. UNITED STATES GALACTOSEMIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 139. UNITED STATES GALACTOSEMIA MARKET SIZE, BY CLASSIC GALACTOSEMIA, 2018-2030 (USD MILLION)
TABLE 140. UNITED STATES GALACTOSEMIA MARKET SIZE, BY DIAGNOSIS METHODS, 2018-2030 (USD MILLION)
TABLE 141. UNITED STATES GALACTOSEMIA MARKET SIZE, BY NEWBORN SCREENING TESTS, 2018-2030 (USD MILLION)
TABLE 142. UNITED STATES GALACTOSEMIA MARKET SIZE, BY TREATMENT APPROACHES, 2018-2030 (USD MILLION)
TABLE 143. UNITED STATES GALACTOSEMIA MARKET SIZE, BY DIETARY MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 144. UNITED STATES GALACTOSEMIA MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 145. UNITED STATES GALACTOSEMIA MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 146. UNITED STATES GALACTOSEMIA MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 147. UNITED STATES GALACTOSEMIA MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 148. UNITED STATES GALACTOSEMIA MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 149. UNITED STATES GALACTOSEMIA MARKET SIZE, BY FORMULAS, 2018-2030 (USD MILLION)
TABLE 150. UNITED STATES GALACTOSEMIA MARKET SIZE, BY SUPPLEMENTS, 2018-2030 (USD MILLION)
TABLE 151. UNITED STATES GALACTOSEMIA MARKET SIZE, BY TESTS AND ASSAYS, 2018-2030 (USD MILLION)
TABLE 152. UNITED STATES GALACTOSEMIA MARKET SIZE, BY CONFIRMATORY TESTS, 2018-2030 (USD MILLION)
TABLE 153. UNITED STATES GALACTOSEMIA MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 154. ASIA-PACIFIC GALACTOSEMIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 155. ASIA-PACIFIC GALACTOSEMIA MARKET SIZE, BY CLASSIC GALACTOSEMIA, 2018-2030 (USD MILLION)
TABLE 156. ASIA-PACIFIC GALACTOSEMIA MARKET SIZE, BY DIAGNOSIS METHODS, 2018-2030 (USD MILLION)
TABLE 157. ASIA-PACIFIC GALACTOSEMIA MARKET SIZE, BY NEWBORN SCREENING TESTS, 2018-2030 (USD MILLION)
TABLE 158. ASIA-PACIFIC GALACTOSEMIA MARKET SIZE, BY TREATMENT APPROACHES, 2018-2030 (USD MILLION)
TABLE 159. ASIA-PACIFIC GALACTOSEMIA MARKET SIZE, BY DIETARY MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 160. ASIA-PACIFIC GALACTOSEMIA MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 161. ASIA-PACIFIC GALACTOSEMIA MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 162. ASIA-PACIFIC GALACTOSEMIA MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 163. ASIA-PACIFIC GALACTOSEMIA MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 164. ASIA-PACIFIC GALACTOSEMIA MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 165. ASIA-PACIFIC GALACTOSEMIA MARKET SIZE, BY FORMULAS, 2018-2030 (USD MILLION)
TABLE 166. ASIA-PACIFIC GALACTOSEMIA MARKET SIZE, BY SUPPLEMENTS, 2018-2030 (USD MILLION)
TABLE 167. ASIA-PACIFIC GALACTOSEMIA MARKET SIZE, BY TESTS AND ASSAYS, 2018-2030 (USD MILLION)
TABLE 168. ASIA-PACIFIC GALACTOSEMIA MARKET SIZE, BY CONFIRMATORY TESTS, 2018-2030 (USD MILLION)
TABLE 169. ASIA-PACIFIC GALACTOSEMIA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 170. AUSTRALIA GALACTOSEMIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 171. AUSTRALIA GALACTOSEMIA MARKET SIZE, BY CLASSIC GALACTOSEMIA, 2018-2030 (USD MILLION)
TABLE 172. AUSTRALIA GALACTOSEMIA MARKET SIZE, BY DIAGNOSIS METHODS, 2018-2030 (USD MILLION)
TABLE 173. AUSTRALIA GALACTOSEMIA MARKET SIZE, BY NEWBORN SCREENING TESTS, 2018-2030 (USD MILLION)
TABLE 174. AUSTRALIA GALACTOSEMIA MARKET SIZE, BY TREATMENT APPROACHES, 2018-2030 (USD MILLION)
TABLE 175. AUSTRALIA GALACTOSEMIA MARKET SIZE, BY DIETARY MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 176. AUSTRALIA GALACTOSEMIA MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 177. AUSTRALIA GALACTOSEMIA MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 178. AUSTRALIA GALACTOSEMIA MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 179. AUSTRALIA GALACTOSEMIA MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 180. AUSTRALIA GALACTOSEMIA MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 181. AUSTRALIA GALACTOSEMIA MARKET SIZE, BY FORMULAS, 2018-2030 (USD MILLION)
TABLE 182. AUSTRALIA GALACTOSEMIA MARKET SIZE, BY SUPPLEMENTS, 2018-2030 (USD MILLION)
TABLE 183. AUSTRALIA GALACTOSEMIA MARKET SIZE, BY TESTS AND ASSAYS, 2018-2030 (USD MILLION)
TABLE 184. AUSTRALIA GALACTOSEMIA MARKET SIZE, BY CONFIRMATORY TESTS, 2018-2030 (USD MILLION)
TABLE 185. CHINA GALACTOSEMIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 186. CHINA GALACTOSEMIA MARKET SIZE, BY CLASSIC GALACTOSEMIA, 2018-2030 (USD MILLION)
TABLE 187. CHINA GALACTOSEMIA MARKET SIZE, BY DIAGNOSIS METHODS, 2018-2030 (USD MILLION)
TABLE 188. CHINA GALACTOSEMIA MARKET SIZE, BY NEWBORN SCREENING TESTS, 2018-2030 (USD MILLION)
TABLE 189. CHINA GALACTOSEMIA MARKET SIZE, BY TREATMENT APPROACHES, 2018-2030 (USD MILLION)
TABLE 190. CHINA GALACTOSEMIA MARKET SIZE, BY DIETARY MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 191. CHINA GALACTOSEMIA MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 192. CHINA GALACTOSEMIA MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 193. CHINA GALACTOSEMIA MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 194. CHINA GALACTOSEMIA MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 195. CHINA GALACTOSEMIA MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 196. CHINA GALACTOSEMIA MARKET SIZE, BY FORMULAS, 2018-2030 (USD MILLION)
TABLE 197. CHINA GALACTOSEMIA MARKET SIZE, BY SUPPLEMENTS, 2018-2030 (USD MILLION)
TABLE 198. CHINA GALACTOSEMIA MARKET SIZE, BY TESTS AND ASSAYS, 2018-2030 (USD MILLION)
TABLE 199. CHINA GALACTOSEMIA MARKET SIZE, BY CONFIRMATORY TESTS, 2018-2030 (USD MILLION)
TABLE 200. INDIA GALACTOSEMIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 201. INDIA GALACTOSEMIA MARKET SIZE, BY CLASSIC GALACTOSEMIA, 2018-2030 (USD MILLION)
TABLE 202. INDIA GALACTOSEMIA MARKET SIZE, BY DIAGNOSIS METHODS, 2018-2030 (USD MILLION)
TABLE 203. INDIA GALACTOSEMIA MARKET SIZE, BY NEWBORN SCREENING TESTS, 2018-2030 (USD MILLION)
TABLE 204. INDIA GALACTOSEMIA MARKET SIZE, BY TREATMENT APPROACHES, 2018-2030 (USD MILLION)
TABLE 205. INDIA GALACTOSEMIA MARKET SIZE, BY DIETARY MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 206. INDIA GALACTOSEMIA MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 207. INDIA GALACTOSEMIA MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 208. INDIA GALACTOSEMIA MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 209. INDIA GALACTOSEMIA MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 210. INDIA GALACTOSEMIA MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 211. INDIA GALACTOSEMIA MARKET SIZE, BY FORMULAS, 2018-2030 (USD MILLION)
TABLE 212. INDIA GALACTOSEMIA MARKET SIZE, BY SUPPLEMENTS, 2018-2030 (USD MILLION)
TABLE 213. INDIA GALACTOSEMIA MARKET SIZE, BY TESTS AND ASSAYS, 2018-2030 (USD MILLION)
TABLE 214. INDIA GALACTOSEMIA MARKET SIZE, BY CONFIRMATORY TESTS, 2018-2030 (USD MILLION)
TABLE 215. INDONESIA GALACTOSEMIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 216. INDONESIA GALACTOSEMIA MARKET SIZE, BY CLASSIC GALACTOSEMIA, 2018-2030 (USD MILLION)
TABLE 217. INDONESIA GALACTOSEMIA MARKET SIZE, BY DIAGNOSIS METHODS, 2018-2030 (USD MILLION)
TABLE 218. INDONESIA GALACTOSEMIA MARKET SIZE, BY NEWBORN SCREENING TESTS, 2018-2030 (USD MILLION)
TABLE 219. INDONESIA GALACTOSEMIA MARKET SIZE, BY TREATMENT APPROACHES, 2018-2030 (USD MILLION)
TABLE 220. INDONESIA GALACTOSEMIA MARKET SIZE, BY DIETARY MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 221. INDONESIA GALACTOSEMIA MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 222. INDONESIA GALACTOSEMIA MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 223. INDONESIA GALACTOSEMIA MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 224. INDONESIA GALACTOSEMIA MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 225. INDONESIA GALACTOSEMIA MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 226. INDONESIA GALACTOSEMIA MARKET SIZE, BY FORMULAS, 2018-2030 (USD MILLION)
TABLE 227. INDONESIA GALACTOSEMIA MARKET SIZE, BY SUPPLEMENTS, 2018-2030 (USD MILLION)
TABLE 228. INDONESIA GALACTOSEMIA MARKET SIZE, BY TESTS AND ASSAYS, 2018-2030 (USD MILLION)
TABLE 229. INDONESIA GALACTOSEMIA MARKET SIZE, BY CONFIRMATORY TESTS, 2018-2030 (USD MILLION)
TABLE 230. JAPAN GALACTOSEMIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 231. JAPAN GALACTOSEMIA MARKET SIZE, BY CLASSIC GALACTOSEMIA, 2018-2030 (USD MILLION)
TABLE 232. JAPAN GALACTOSEMIA MARKET SIZE, BY DIAGNOSIS METHODS, 2018-2030 (USD MILLION)
TABLE 233. JAPAN GALACTOSEMIA MARKET SIZE, BY NEWBORN SCREENING TESTS, 2018-2030 (USD MILLION)
TABLE 234. JAPAN GALACTOSEMIA MARKET SIZE, BY TREATMENT APPROACHES, 2018-2030 (USD MILLION)
TABLE 235. JAPAN GALACTOSEMIA MARKET SIZE, BY DIETARY MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 236. JAPAN GALACTOSEMIA MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 237. JAPAN GALACTOSEMIA MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 238. JAPAN GALACTOSEMIA MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 239. JAPAN GALACTOSEMIA MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 240. JAPAN GALACTOSEMIA MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 241. JAPAN GALACTOSEMIA MARKET SIZE, BY FORMULAS, 2018-2030 (USD MILLION)
TABLE 242. JAPAN GALACTOSEMIA MARKET SIZE, BY SUPPLEMENTS, 2018-2030 (USD MILLION)
TABLE 243. JAPAN GALACTOSEMIA MARKET SIZE, BY TESTS AND ASSAYS, 2018-2030 (USD MILLION)
TABLE 244. JAPAN GALACTOSEMIA MARKET SIZE, BY CONFIRMATORY TESTS, 2018-2030 (USD MILLION)
TABLE 245. MALAYSIA GALACTOSEMIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 246. MALAYSIA GALACTOSEMIA MARKET SIZE, BY CLASSIC GALACTOSEMIA, 2018-2030 (USD MILLION)
TABLE 247. MALAYSIA GALACTOSEMIA MARKET SIZE, BY DIAGNOSIS METHODS, 2018-2030 (USD MILLION)
TABLE 248. MALAYSIA GALACTOSEMIA MARKET SIZE, BY NEWBORN SCREENING TESTS, 2018-2030 (USD MILLION)
TABLE 249. MALAYSIA GALACTOSEMIA MARKET SIZE, BY TREATMENT APPROACHES, 2018-2030 (USD MILLION)
TABLE 250. MALAYSIA GALACTOSEMIA MARKET SIZE, BY DIETARY MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 251. MALAYSIA GALACTOSEMIA MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 252. MALAYSIA GALACTOSEMIA MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 253. MALAYSIA GALACTOSEMIA MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 254. MALAYSIA GALACTOSEMIA MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 255. MALAYSIA GALACTOSEMIA MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 256. MALAYSIA GALACTOSEMIA MARKET SIZE, BY FORMULAS, 2018-2030 (USD MILLION)
TABLE 257. MALAYSIA GALACTOSEMIA MARKET SIZE, BY SUPPLEMENTS, 2018-2030 (USD MILLION)
TABLE 258. MALAYSIA GALACTOSEMIA MARKET SIZE, BY TESTS AND ASSAYS, 2018-2030 (USD MILLION)
TABLE 259. MALAYSIA GALACTOSEMIA MARKET SIZE, BY CONFIRMATORY TESTS, 2018-2030 (USD MILLION)
TABLE 260. PHILIPPINES GALACTOSEMIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 261. PHILIPPINES GALACTOSEMIA MARKET SIZE, BY CLASSIC GALACTOSEMIA, 2018-2030 (USD MILLION)
TABLE 262. PHILIPPINES GALACTOSEMIA MARKET SIZE, BY DIAGNOSIS METHODS, 2018-2030 (USD MILLION)
TABLE 263. PHILIPPINES GALACTOSEMIA MARKET SIZE, BY NEWBORN SCREENING TESTS, 2018-2030 (USD MILLION)
TABLE 264. PHILIPPINES GALACTOSEMIA MARKET SIZE, BY TREATMENT APPROACHES, 2018-2030 (USD MILLION)
TABLE 265. PHILIPPINES GALACTOSEMIA MARKET SIZE, BY DIETARY MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 266. PHILIPPINES GALACTOSEMIA MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 267. PHILIPPINES GALACTOSEMIA MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 268. PHILIPPINES GALACTOSEMIA MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 269. PHILIPPINES GALACTOSEMIA MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 270. PHILIPPINES GALACTOSEMIA MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 271. PHILIPPINES GALACTOSEMIA MARKET SIZE, BY FORMULAS, 2018-2030 (USD MILLION)
TABLE 272. PHILIPPINES GALACTOSEMIA MARKET SIZE, BY SUPPLEMENTS, 2018-2030 (USD MILLION)
TABLE 273. PHILIPPINES GALACTOSEMIA MARKET SIZE, BY TESTS AND ASSAYS, 2018-2030 (USD MILLION)
TABLE 274. PHILIPPINES GALACTOSEMIA MARKET SIZE, BY CONFIRMATORY TESTS, 2018-2030 (USD MILLION)
TABLE 275. SINGAPORE GALACTOSEMIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 276. SINGAPORE GALACTOSEMIA MARKET SIZE, BY CLASSIC GALACTOSEMIA, 2018-2030 (USD MILLION)
TABLE 277. SINGAPORE GALACTOSEMIA MARKET SIZE, BY DIAGNOSIS METHODS, 2018-2030 (USD MILLION)
TABLE 278. SINGAPORE GALACTOSEMIA MARKET SIZE, BY NEWBORN SCREENING TESTS, 2018-2030 (USD MILLION)
TABLE 279. SINGAPORE GALACTOSEMIA MARKET SIZE, BY TREATMENT APPROACHES, 2018-2030 (USD MILLION)
TABLE 280. SINGAPORE GALACTOSEMIA MARKET SIZE, BY DIETARY MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 281. SINGAPORE GALACTOSEMIA MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 282. SINGAPORE GALACTOSEMIA MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 283. SINGAPORE GALACTOSEMIA MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 284. SINGAPORE GALACTOSEMIA MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 285. SINGAPORE GALACTOSEMIA MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 286. SINGAPORE GALACTOSEMIA MARKET SIZE, BY FORMULAS, 2018-2030 (USD MILLION)
TABLE 287. SINGAPORE GALACTOSEMIA MARKET SIZE, BY SUPPLEMENTS, 2018-2030 (USD MILLION)
TABLE 288. SINGAPORE GALACTOSEMIA MARKET SIZE, BY TESTS AND ASSAYS, 2018-2030 (USD MILLION)
TABLE 289. SINGAPORE GALACTOSEMIA MARKET SIZE, BY CONFIRMATORY TESTS, 2018-2030 (USD MILLION)
TABLE 290. SOUTH KOREA GALACTOSEMIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 291. SOUTH KOREA GALACTOSEMIA MARKET SIZE, BY CLASSIC GALACTOSEMIA, 2018-2030 (USD MILLION)
TABLE 292. SOUTH KOREA GALACTOSEMIA MARKET SIZE, BY DIAGNOSIS METHODS, 2018-2030 (USD MILLION)
TABLE 293. SOUTH KOREA GALACTOSEMIA MARKET SIZE, BY NEWBORN SCREENING TESTS, 2018-2030 (USD MILLION)
TABLE 294. SOUTH KOREA GALACTOSEMIA MARKET SIZE, BY TREATMENT APPROACHES, 2018-2030 (USD MILLION)
TABLE 295. SOUTH KOREA GALACTOSEMIA MARKET SIZE, BY DIETARY MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 296. SOUTH KOREA GALACTOSEMIA MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 297. SOUTH KOREA GALACTOSEMIA MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 298. SOUTH KOREA GALACTOSEMIA MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 299. SOUTH KOREA GALACTOSEMIA MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 300. SOUTH KOREA GALACTOSEMIA MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 301. SOUTH KOREA GALACTOSEMIA MARKET SIZE, BY FORMULAS, 2018-2030 (USD MILLION)
TABLE 302. SOUTH KOREA GALACTOSEMIA MARKET SIZE, BY SUPPLEMENTS, 2018-2030 (USD MILLION)
TABLE 303. SOUTH KOREA GALACTOSEMIA MARKET SIZE, BY TESTS AND ASSAYS, 2018-2030 (USD MILLION)
TABLE 304. SOUTH KOREA GALACTOSEMIA MARKET SIZE, BY CONFIRMATORY TESTS, 2018-2030 (USD MILLION)
TABLE 305. TAIWAN GALACTOSEMIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 306. TAIWAN GALACTOSEMIA MARKET SIZE, BY CLASSIC GALACTOSEMIA, 2018-2030 (USD MILLION)
TABLE 307. TAIWAN GALACTOSEMIA MARKET SIZE, BY DIAGNOSIS METHODS, 2018-2030 (USD MILLION)
TABLE 308. TAIWAN GALACTOSEMIA MARKET SIZE, BY NEWBORN SCREENING TESTS, 2018-2030 (USD MILLION)
TABLE 309. TAIWAN GALACTOSEMIA MARKET SIZE, BY TREATMENT APPROACHES, 2018-2030 (USD MILLION)
TABLE 310. TAIWAN GALACTOSEMIA MARKET SIZE, BY DIETARY MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 311. TAIWAN GALACTOSEMIA MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 312. TAIWAN GALACTOSEMIA MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 313. TAIWAN GALACTOSEMIA MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 314. TAIWAN GALACTOSEMIA MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 315. TAIWAN GALACTOSEMIA MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 316. TAIWAN GALACTOSEMIA MARKET SIZE, BY FORMULAS, 2018-2030 (USD MILLION)
TABLE 317. TAIWAN GALACTOSEMIA MARKET SIZE, BY SUPPLEMENTS, 2018-2030 (USD MILLION)
TABLE 318. TAIWAN GALACTOSEMIA MARKET SIZE, BY TESTS AND ASSAYS, 2018-2030 (USD MILLION)
TABLE 319. TAIWAN GALACTOSEMIA MARKET SIZE, BY CONFIRMATORY TESTS, 2018-2030 (USD MILLION)
TABLE 320. THAILAND GALACTOSEMIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 321. THAILAND GALACTOSEMIA MARKET SIZE, BY CLASSIC GALACTOSEMIA, 2018-2030 (USD MILLION)
TABLE 322. THAILAND GALACTOSEMIA MARKET SIZE, BY DIAGNOSIS METHODS, 2018-2030 (USD MILLION)
TABLE 323. THAILAND GALACTOSEMIA MARKET SIZE, BY NEWBORN SCREENING TESTS, 2018-2030 (USD MILLION)
TABLE 324. THAILAND GALACTOSEMIA MARKET SIZE, BY TREATMENT APPROACHES, 2018-2030 (USD MILLION)
TABLE 325. THAILAND GALACTOSEMIA MARKET SIZE, BY DIETARY MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 326. THAILAND GALACTOSEMIA MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 327. THAILAND GALACTOSEMIA MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 328. THAILAND GALACTOSEMIA MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 329. THAILAND GALACTOSEMIA MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 330. THAILAND GALACTOSEMIA MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 331. THAILAND GALACTOSEMIA MARKET SIZE, BY FORMULAS, 2018-2030 (USD MILLION)
TABLE 332. THAILAND GALACTOSEMIA MARKET SIZE, BY SUPPLEMENTS, 2018-2030 (USD MILLION)
TABLE 333. THAILAND GALACTOSEMIA MARKET SIZE, BY TESTS AND ASSAYS, 2018-2030 (USD MILLION)
TABLE 334. THAILAND GALACTOSEMIA MARKET SIZE, BY CONFIRMATORY TESTS, 2018-2030 (USD MILLION)
TABLE 335. VIETNAM GALACTOSEMIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 336. VIETNAM GALACTOSEMIA MARKET SIZE, BY CLASSIC GALACTOSEMIA, 2018-2030 (USD MILLION)
TABLE 337. VIETNAM GALACTOSEMIA MARKET SIZE, BY DIAGNOSIS METHODS, 2018-2030 (USD MILLION)
TABLE 338. VIETNAM GALACTOSEMIA MARKET SIZE, BY NEWBORN SCREENING TESTS, 2018-2030 (USD MILLION)
TABLE 339. VIETNAM GALACTOSEMIA MARKET SIZE, BY TREATMENT APPROACHES, 2018-2030 (USD MILLION)
TABLE 340. VIETNAM GALACTOSEMIA MARKET SIZE, BY DIETARY MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 341. VIETNAM GALACTOSEMIA MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 342. VIETNAM GALACTOSEMIA MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 343. VIETNAM GALACTOSEMIA MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 344. VIETNAM GALACTOSEMIA MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 345. VIETNAM GALACTOSEMIA MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 346. VIETNAM GALACTOSEMIA MARKET SIZE, BY FORMULAS, 2018-2030 (USD MILLION)
TABLE 347. VIETNAM GALACTOSEMIA MARKET SIZE, BY SUPPLEMENTS, 2018-2030 (USD MILLION)
TABLE 348. VIETNAM GALACTOSEMIA MARKET SIZE, BY TESTS AND ASSAYS, 2018-2030 (USD MILLION)
TABLE 349. VIETNAM GALACTOSEMIA MARKET SIZE, BY CONFIRMATORY TESTS, 2018-2030 (USD MILLION)
TABLE 350. EUROPE, MIDDLE EAST & AFRICA GALACTOSEMIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 351. EUROPE, MIDDLE EAST & AFRICA GALACTOSEMIA MARKET SIZE, BY CLASSIC GALACTOSEMIA, 2018-2030 (USD MILLION)
TABLE 352. EUROPE, MIDDLE EAST & AFRICA GALACTOSEMIA MARKET SIZE, BY DIAGNOSIS METHODS, 2018-2030 (USD MILLION)
TABLE 353. EUROPE, MIDDLE EAST & AFRICA GALACTOSEMIA MARKET SIZE, BY NEWBORN SCREENING TESTS, 2018-2030 (USD MILLION)
TABLE 354. EUROPE, MIDDLE EAST & AFRICA GALACTOSEMIA MARKET SIZE, BY TREATMENT APPROACHES, 2018-2030 (USD MILLION)
TABLE 355. EUROPE, MIDDLE EAST & AFRICA GALACTOSEMIA MARKET SIZE, BY DIETARY MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 356. EUROPE, MIDDLE EAST & AFRICA GALACTOSEMIA MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 357. EUROPE, MIDDLE EAST & AFRICA GALACTOSEMIA MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 358. EUROPE, MIDDLE EAST & AFRICA GALACTOSEMIA MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 359. EUROPE, MIDDLE EAST & AFRICA GALACTOSEMIA MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 360. EUROPE, MIDDLE EAST & AFRICA GALACTOSEMIA MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 361. EUROPE, MIDDLE EAST & AFRICA GALACTOSEMIA MARKET SIZE, BY FORMULAS, 2018-2030 (USD MILLION)
TABLE 362. EUROPE, MIDDLE EAST & AFRICA GALACTOSEMIA MARKET SIZE, BY SUPPLEMENTS, 2018-2030 (USD MILLION)
TABLE 363. EUROPE, MIDDLE EAST & AFRICA GALACTOSEMIA MARKET SIZE, BY TESTS AND ASSAYS, 201

Companies Mentioned

The leading players in the Galactosemia Market, which are profiled in this report, include:
  • AbbVie
  • Amgen
  • Audentes Therapeutics
  • BioMarin Pharmaceutical Inc.
  • BridgeBio Pharma
  • Erytech Pharma
  • GlaxoSmithKline
  • Hospira
  • Johnson & Johnson
  • LogicBio Therapeutics
  • Moderna
  • Novartis
  • Orphalan
  • Pfizer
  • Roche
  • Sanofi
  • Sarepta Therapeutics
  • Ultragenyx Pharmaceutical Inc.
  • uniQure
  • Vertex Pharmaceuticals

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages194
PublishedOctober 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 531.54 Million
Forecasted Market Value ( USD ) by 2030 $ 802.53 Million
Compound Annual Growth Rate6.8%
Regions CoveredGlobal
No. of Companies Mentioned21

Related Topics

Related Reports

Galactosemia - Market Insight, Epidemiology and Market Forecast - 2034 - Product Image

Galactosemia - Market Insight, Epidemiology and Market Forecast - 2034

  • Report
  • 200 Pages
  • Global
From
Galactosemia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034 - Product Image

Galactosemia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

  • Report
  • 137 Pages
  • Global
From
Galactosemia - Pipeline Insight, 2024 - Product Image

Galactosemia - Pipeline Insight, 2024

  • Clinical Trials
  • 60 Pages
  • Global
From
Congenital Adrenal Hyperplasia Treatment Market by Type, Treatments, End-User - Global Forecast 2025-2030 - Product Image

Congenital Adrenal Hyperplasia Treatment Market by Type, Treatments, End-User - Global Forecast 2025-2030

  • Report
  • 185 Pages
  • Global
From
Gaucher Disease Treatment Market by Type, Treatment, Diagnosis, Distribution Channel - Global Forecast 2025-2030 - Product Image

Gaucher Disease Treatment Market by Type, Treatment, Diagnosis, Distribution Channel - Global Forecast 2025-2030

  • Report
  • 198 Pages
  • Global
From

About the Galactosemia Drug Market

Galactosemia is a rare genetic disorder that affects the metabolism of galactose, a sugar found in dairy products and other foods. Endocrine and Metabolic Disorders Drugs are used to treat this disorder. These drugs are used to reduce the amount of galactose in the body, as well as to reduce the symptoms associated with the disorder. Common drugs used to treat galactosemia include galactose-1-phosphate uridyltransferase (GALT) enzyme replacement therapy, galactose-restricted diet, and lactose-free diet. The Galactosemia Drug market is a niche market, with a limited number of drugs available to treat the disorder. The market is expected to grow in the coming years, as more research is conducted into the disorder and new treatments are developed. Some companies in the Galactosemia Drug market include Sanofi, Pfizer, Novartis, and Merck. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.